WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009142195) AGENT FOR INDUCTION/MAINTENANCE OF REMISSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/142195    International Application No.:    PCT/JP2009/059176
Publication Date: 26.11.2009 International Filing Date: 19.05.2009
IPC:
A61K 45/00 (2006.01), A61K 31/137 (2006.01), A61K 31/42 (2006.01), A61K 31/519 (2006.01), A61K 31/7056 (2006.01), A61K 38/00 (2006.01), A61P 1/04 (2006.01), A61P 11/06 (2006.01), A61P 13/12 (2006.01), A61P 17/06 (2006.01), A61P 19/02 (2006.01), A61P 21/04 (2006.01), A61P 25/00 (2006.01), A61P 29/00 (2006.01), A61P 37/02 (2006.01), A61P 37/08 (2006.01), A61P 43/00 (2006.01)
Applicants: KYORIN PHARMACEUTICAL CO., LTD. [JP/JP]; 5, Kanda Surugadai 2-chome, Chiyoda-ku, Tokyo 1018311 (JP) (For All Designated States Except US).
KURIYAMA Kazuhiko [JP/JP]; (JP) (For US Only).
KAGO Tomoyuki [JP/JP]; (JP) (For US Only).
YASUE Tokutaro [JP/JP]; (JP) (For US Only)
Inventors: KURIYAMA Kazuhiko; (JP).
KAGO Tomoyuki; (JP).
YASUE Tokutaro; (JP)
Agent: KUMAKURA Yoshio; NAKAMURA & PARTNERS Shin-Tokyo Bldg. 3-1, Marunouchi 3-chome Chiyoda-ku, Tokyo 1008355 (JP)
Priority Data:
2008-131634 20.05.2008 JP
Title (EN) AGENT FOR INDUCTION/MAINTENANCE OF REMISSION
(FR) AGENT D’INDUCTION/D’ENTRETIEN DE RÉMISSION
(JA) 寛解導入維持剤
Abstract: front page image
(EN)Disclosed is a method for inducing/maintaining remission of an immune disease, which can reduce serious adverse side effects and stress in a patient. After the induction of remission of an immune disease with a biological substance or a nucleic acid synthesis inhibitor, a sphingosine-1-phosphate receptor agonist is used.
(FR)La présente invention concerne une méthode permettant d’induire/d’entretenir la rémission  d’une maladie immunitaire, qui peut réduire les effets secondaires graves et le stress chez un patient. Après l’induction de la rémission d’une maladie immunitaire avec une substance biologique ou un inhibiteur de la synthèse d’acide nucléique, un agoniste des récepteurs de la sphingosine-1-phosphate est utilisé.
(JA) 重篤な副作用及び患者負担の軽減された免疫疾患の寛解導入維持方法を提供する。 生物学的薬剤又は核酸合成阻害剤による免疫疾患の寛解導入後に、スフィンゴシン-1-リン酸受容体アゴニストを使用する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)